# Grace Therapeutics, Inc.: Form DEF 14A, filed Jul 28, 2026

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: DEF 14A
- Filed: 2026-07-28
- Accepted by EDGAR: Jul 28, 2026, 16:29 ET
- Period: 2026-09-17
- Accession: 0001140361-26-029889
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000114036126029889/ny20076473x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000114036126029889/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000114036126029889/ny20076473x1_def14a.htm

Filed Jul 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-029889. Last ingested by Listed: Nov 14, 2026, 23:10 ET. No prices; not investment advice.
